Inquiry Basket
Loading ......
Filter By Product Search for
Tylosin
TYLOSIN Full Name
Tylosin
TYLOSIN Introduction
Tylosin is a widely used macrolide antibiotic in veterinary medicine, particularly valued for its efficacy against Gram-positive bacteria and certain mycoplasma species that are difficult to control in livestock production. One of the key challenges for researchers and veterinarians is understanding why treatment outcomes can vary significantly even when pathogens appear susceptible in vitro. At the molecular level, tylosin exerts its antibacterial activity by targeting the bacterial ribosome, specifically binding to the 50S subunit and interacting with domain V of the 23S rRNA. This binding blocks the peptide exit tunnel, thereby inhibiting protein elongation and ultimately suppressing bacterial growth. Because this target is highly conserved across many bacterial species, tylosin has broad-spectrum activity, but this also creates strong selective pressure that accelerates the emergence of resistance in complex microbial ecosystems such as the gastrointestinal tract of food-producing animals.
From a functional perspective, the primary biological target of tylosin—23S rRNA within the ribosomal peptidyl transferase center—is central to protein synthesis, making it a critical node in bacterial survival and proliferation. However, a major pain point in both research and clinical settings is the rapid loss of tylosin efficacy due to target-site modification. The most well-characterized mechanism involves the erm (erythromycin ribosome methylation) gene family, particularly erm(B), which encodes an rRNA methyltransferase. This enzyme methylates specific adenine residues (commonly A2058 or nearby sites) in the 23S rRNA, directly overlapping with the tylosin binding site and preventing antibiotic interaction. In addition, inducible and constitutive expression patterns of erm genes (iMLS_B and cMLS_B phenotypes) complicate susceptibility testing, as bacteria may appear sensitive under standard conditions but become resistant upon antibiotic exposure. Other mechanisms, such as active efflux mediated by msr genes encoding ATP-binding cassette (ABC) transporters, further reduce intracellular drug accumulation and contribute to multidrug resistance phenotypes.
Clinically and environmentally, tylosin is closely associated with the development and dissemination of antimicrobial resistance, which remains a critical global health concern. In livestock systems, prolonged tylosin use has been strongly linked to increased abundance of resistance genes such as erm(B) in enteric bacteria, including Enterococcus and Staphylococcus species, which can act as reservoirs for horizontal gene transfer. This creates a significant translational challenge: resistance determinants selected in agricultural settings may spread to human-associated pathogens through food chains, environmental contamination, or direct contact. Moreover, recent studies highlight that tylosin residues and resistance genes persist in soil and aquatic environments, amplifying ecological risks and complicating mitigation strategies. Understanding the interplay between tylosin's ribosomal target, resistance gene dynamics, and microbial ecology is therefore essential for developing more sustainable antimicrobial practices and for designing next-generation therapeutics that can overcome or bypass ribosomal modification-based resistance.
Alternate Names for TYLOSIN
Tylosin; Tilmicosin;
Loading ......
